The 2022 CDC opioid guideline removed the previous 3-day and 7-day limits on opioid prescribing for acute pain that were in the 2016 guideline.
Notes on verification
Confirmed directly by CDC's 2022 MMWR guideline text and corroborated by independent summaries (ASHP, Texas DSHS comparison, clinical trial protocol documentation) all describing removal of rigid 3-day/7-day limits in favor of flexible, patient-centered guidance. [tier=gold indep_score=1.0 clusters=4 claim_tier=notable]
Sources
- CDC releases updated guideline for prescribing opioids for pain (seed:health_and_medicine)
- CDC Clinical Practice Guideline for Prescribing Opioids ... (seed:health_and_medicine)
- https://www.ashp.org/-/media/assets/pharmacy-practice/resource-centers/ambulatory-care/docs/2022-CDC-Opioid-Prescribing-Guideline-Updates.pdf (corroboration)
- https://www.dshs.texas.gov/sites/default/files/injury/TODA/PDFs/2016-vs-2022-CDC-Practice-Guidelines.pdf (corroboration)
- https://cdn.clinicaltrials.gov/large-docs/84/NCT03773484/Prot_SAP_000.pdf (corroboration)